Europe Pharmaceutical Drugs Market,Drug Type (Generic Drugs and Branded Drugs), by Product Type (Prescription Drugs and Over the Counter Drugs), by Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Central Nervous System, Genito-urinary, Gastrointestinal, Respiratory, Hematology, Dermatology, Ophthalmology, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and by Country (Germany, France, U.K., Italy, Spain, Russia, The Netherlands, Poland, Switzerland, Sweden, and Rest of Europe)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Pharmaceutical drugs are used for the treatment of chronic and acute diseases. There are two types of pharmaceutical drugs: generic and branded, which are sold through prescription and over the counter (OTC). A pharmaceutical drug that shares the same chemical component as a drug that was originally covered by chemical patents is known as a generic drug.Generic drugs are allowed for sale after the patents on the original drugs expire.Generics perform similarly in terms of the medical profile due to the identical active chemical substance. Generic drugs are similar to branded drugs and are less expensive as compared to branded drugs.
Increasing prevalence of diseases such as cardiovascular disorders, cancer, and metabolic disorders, as well as product launches, patent expiration of branded drugs, and other diseases, and the presence of favorable reimbursement policies are expected to increase demand for the pharmaceutical drug market in Europe during the forecast period. A brand drug is the innovator drug and gets patent and exclusivity protection. Pharmaceutical drugs are composed of chemical compounds which are used for the prevention and treatment of diseases and are administered intravenously, orally, intramuscularly, or by other routes of administration. Pharmaceutical drugs are of two types; generic and branded. Pharmaceutical drugs are subjected to numerous regulations with respect to patenting, clinical trials, drug safety, efficacy, and marketing in Europe region.
Market Dynamics
The patent expiry of branded products is paving the way for the entry of generic drugs into the market. Moreover, adoption of inorganic and organic strategies such as mergers and acquisitions, and product developments by key players to expand their product portfolio is expected to drive the growth of the Europe pharmaceutical drugs market. For instance, on January 2020, Novartis AG- a U.S based biopharmaceutical company, received the European Commission’s approval for MAyznet for the treatment of secondary progressive multiple sclerosis (SPMS) in adult patients.
Key features of the study:
This report provides in-depth analysis of the Europe pharmaceutical drugs market and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players.
It profiles key players in the Europe pharmaceutical drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
Major players operating in the Europe pharmaceutical drugs market are Allergan plc. (A subsidiary of AbbVie Inc.),Novo Nordisk A/S, Boehringer Ingelheim, Merck KGaA, GlaxoSmithKline plc., AstraZeneca., Baxter, Novartis AG, F. Hoffmann-La Roche Ltd, Shire (A subsidiary of Takeda Pharmaceutical Company Limited), and Sanofi.
Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics.
The Europe pharmaceutical drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe pharmaceutical drugs market .
Detailed Segmentation:
Europe Pharmaceutical Drugs Market, By Drug Type:
Generic Drugs
Branded Drugs
Europe Pharmaceutical Drug Market, By Product Type:
Prescription Drugs
Over-the-counter (OTC) Drugs
Europe Pharmaceutical Drug Market, By Application:
Cardiovascular
Musculoskeletal
Oncology
Anti-infective
Metabolic Disorder
Central Nervous System
Genito-urinary
Gastrointestinal
Respiratory
Hematology
Dermatology
Ophthalmology
Others
Europe Pharmaceutical Drug Market, By Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Europe Pharmaceutical Drug Market, By Country:
U.K.
Germany
France
Italy
Spain
Russia
Netherlands
Poland
Switzerland
Sweden
Rest of Europe
Company Profiles
Allergan plc (A subsidiary of AbbVie Inc.)
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Market Strategies
Novo Nordiska A/S
Boehringer Ingelheim International GmbH
Merck KGaA
GSK Plc.
AstraZeneca
Baxter
Novartis AG
Hoffmann-La Roche Ltd
Shire (A subsidary of Takeda Pharmaceutical Company Limited)
Sanofi
“*”marked represents similar segmentation in other categories in the respective section.
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Country
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Regulatory scenario
- Key Developments
- Industry trends
- PEST Analysis
- Epidemiology
- Reimbursement scenario
- 4. Europe Pharmaceutical Drugs Market, By Drug Type, 2018 – 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 – 2030(%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Generic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Branded Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- 5. Europe Pharmaceutical Drugs Market, By Product Type, 2018 – 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 – 2030(%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Prescription drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- OTC drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- 6. Europe Pharmaceutical Drugs Market, By Application, 2018 – 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 – 2030(%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Anti-infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Metabolic disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Central Nervous System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Genito-urinary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Gastrointestinal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
- 7. Europe Pharmaceutical Drugs Market, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2023 – 2030(%)
- Y-o-Y Growth Analysis, For Regions, 2018 – 2030
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y , 2018-2030 Growth
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030 (US$ Bn)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
- 8. Europe Pharmaceutical Drugs Market, By Country, 2018–2030, (US$Bn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018–2030
- UK
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 – 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 – 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Bn)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 – 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 – 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2018 – 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 – 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 – 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Russia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 – 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Netherlands
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 – 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Poland
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 – 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Switzerland
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 – 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Sweden
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018– 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Bn)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2018- 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018– 2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 – 2030, (US$ Bn)
- 9. Competitive Landscape
- Company Profiles
- Allergan plc (A subsidiary of AbbVie Inc.)
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novo Nordisk A/S
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GSK plc
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Baxter
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hoffman- La Roche Limited .
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Shire (A subsidiary of Takeda Pharmaceutical Company Limited)
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product form Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- 10. Section
- Research Methodology
- About Us and sales contact
- References
- *Browse 63 market data tables and 68 figures on “Pharmaceutical Drugs Market – Europe forecast to 2030.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook